{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:00:59Z","timestamp":1792886459215,"version":"4.5.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Catheter ablation of atrial fibrillation is an alternative treatment for patients with tachycardia-bradycardia syndrome (TBS) to avoid pacemaker implantation. The risk stratification for atrial fibrillation and outcomes between ablation and pacing has not been fully evaluated.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This retrospective study involved 306 TBS patients, including 141 patients who received catheter ablation (Ablation group, age: 62.2 \u00b1 9.0 months, mean longest pauses: 5.2 \u00b1 2.2 s) and 165 patients who received pacemaker implement (Pacing group, age: 62.3 \u00b1 9.1 months, mean longest pauses: 6.0 \u00b1 2.3 s). The primary endpoint was a composite of call cause mortality, cardiovascular-related hospitalization or thrombosis events (stroke, or peripheral thrombosis). The second endpoint was progress of atrial fibrillation and heart failure.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> After a median follow-up of 75.4 months, the primary endpoint occurred in significantly higher patients in the pacing group than in the ablation group (59.4 vs.15.6%, OR 6.05, 95% CI: 3.73\u20139.80, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). None of deaths was occurred in ablation group, and 1 death occurred due to cancer. Cardiovascular-related hospitalization occurred in 50.9% of the pacing group compared with 14.2% in the ablation group (OR: 4.87, 95% CI: 2.99\u20137.95, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). More thrombosis events occurred in the pacing group than in the ablation group (12.7 vs. 2.1%, OR 6.06, 95% CI: 1.81\u201320.35, <jats:italic>P<\/jats:italic> = 0.004). Significant more patients progressed to persistent atrial fibrillation in pacing group than in ablation group (23.6 vs. 2.1%, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). The NYHA classification of the pacing group was significantly higher than that of the ablation group (2.11 \u00b1 0.83 vs. 1.50 \u00b1 0.74, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). The proportion of antiarrhythmic drugs and anticoagulants used in the pacing group was significantly higher than that in the ablation group (41.2 vs. 7.1%, <jats:italic>P<\/jats:italic> &amp;lt; 0.001; 16.4 vs. 2.1%, <jats:italic>P<\/jats:italic> = 0.009).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Catheter ablation for patients with TBS was associated with a significantly lower rate of a composite end point of cardiovascular related hospitalization and thromboembolic events. Furthermore, catheter ablation reduced the progression of atrial fibrillation and heart failure.<\/jats:p>","DOI":"10.3389\/fcvm.2021.674471","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T04:22:48Z","timestamp":1623126168000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk Stratification for Atrial Fibrillation and Outcomes in Tachycardia-Bradycardia Syndrome: Ablation vs. Pacing"],"prefix":"10.3389","volume":"8","author":[{"given":"Rongfeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianjun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1161\/CIRCEP.113.000151","article-title":"Unusual tachycardia-bradycardia syndrome during atrial fibrillation: what is the mechanism?","volume":"6","author":"Clementy","year":"2013","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3892\/ijmm.2017.2877","article-title":"Tachycardia-bradycardia syndrome: electrophysiological mechanisms and future therapeutic approaches (Review)","volume":"39","author":"Tse","year":"2017","journal-title":"Int J Mol Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1540-8167.2007.00825.x","article-title":"Incessant wide QRS tachycardia after pulmonary vein isolation and pacemaker implantation in a patient with tachycardia-bradycardia syndrome","volume":"18","author":"Lo","year":"2007","journal-title":"J Cardiovasc Electrophysiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/j.hrthm.2017.07.009","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atri al fibrillation: executive summary","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0735-1097(92)90003-6","article-title":"Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in At rial Fibrillation Investigators","volume":"20","author":"Flaker","year":"1992","journal-title":"J Am Coll Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1161\/01.CIR.94.11.2953","article-title":"Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling","volume":"94","author":"Elvan","year":"1996","journal-title":"Circulation."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1161\/01.CIR.0000091408.45747.04","article-title":"Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: implications fo r the mechanisms of tachycardia-mediated atrial cardiomyopathy","volume":"108","author":"Sanders","year":"2003","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0735-1097(96)00592-X","article-title":"Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies","volume":"29","author":"Shinbane","year":"1997","journal-title":"J Am Coll Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1093\/europace\/euy081","article-title":"Implantable cardioverter-defibrillator therapy and device-related complications in young patients wit h inherited cardiomyopathies or channelopathies: a 17-year cohort study","volume":"20","author":"Petersen","year":"2018","journal-title":"Europace."},{"key":"B11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0002-9149(73)90302-0","article-title":"Tachycardia-bradycardia syndrome (so-called sick sinus syndrome). Pathology, mechanisms and treatment","volume":"31","author":"Kaplan","year":"1973","journal-title":"Am J Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.21037\/jtd.2018.01.177","article-title":"Atrial fibrillation is related to lower incidence of deep venous thrombosis in patients with pulmonar y embolism","volume":"10","author":"Waleed","year":"2018","journal-title":"J Thorac Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/europace\/eus045","article-title":"Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardio graphic, clinical, and survival analysis","volume":"14","author":"Dong","year":"2012","journal-title":"Europace."},{"key":"B14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillatio n using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.113.001644","article-title":"Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term pr ogression of atrial fibrillation in sick sinus syndrome: septal pacing for atrial fibrillation suppr ession evaluation (SAFE) study","volume":"128","author":"Lau","year":"2013","journal-title":"Circulation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1093\/europace\/euw364","article-title":"Single lead atrial vs. dual chamber pacing in sick sinus syndrome: extended register-based follow-up in the DANPACE trial","volume":"19","author":"Brandt","year":"2017","journal-title":"Europace."},{"key":"B17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/hrt.2003.016063","article-title":"Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual cham ber pacing in 177 patients with sick sinus syndrome","volume":"90","author":"Kristensen","year":"2004","journal-title":"Heart."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e004549","DOI":"10.1161\/JAHA.112.004549","article-title":"Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis","volume":"2","author":"Ganesan","year":"2013","journal-title":"J Am Heart Assoc."},{"key":"B19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00380-018-1256-8","article-title":"Catheter ablation of paroxysmal atrial fibrillation in patients with sick sinus syndrome","volume":"34","author":"Hada","year":"2019","journal-title":"Heart Vessels."},{"key":"B20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ipej.2017.07.009","article-title":"The proportion of asymptomatic recurrence after catheter ablation of atrial fibrillation in patients with a pacemaker for sick sinus syndrome","volume":"17","author":"Osaka","year":"2017","journal-title":"Indian Pacing Electrophysiol J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/europace\/eut159","article-title":"The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonge d sinus pauses: outcome during a 5-year follow-up","volume":"16","author":"Inada","year":"2014","journal-title":"Europace."},{"key":"B22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/pace.12340","article-title":"Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardi a syndrome?","volume":"37","author":"Chen","year":"2014","journal-title":"Pacing Clin Electrophysiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12872-018-0834-0","article-title":"Long-term clinical outcomes of catheter ablation in patients with atrial fibrillation predisposing to tachycardia-bradycardia syndrome: a long pause predicts implantation of a permanent pacemaker","volume":"18","author":"Kim","year":"2018","journal-title":"BMC Cardiovasc Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1080\/00015385.2019.1630055","article-title":"Long-term effect of catheter ablation on tachycardia-bradycardia syndrome: evidenced by 10 years foll ow up","volume":"75","author":"Zhang","year":"2020","journal-title":"Acta Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.jacc.2018.02.048","article-title":"Clinical outcomes of his bundle pacing compared to right ventricular pacing","volume":"71","author":"Abdelrahman","year":"2018","journal-title":"J Am Coll Cardiol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.674471\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T04:22:50Z","timestamp":1623126170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.674471\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":25,"alternative-id":["10.3389\/fcvm.2021.674471"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.674471","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"article-number":"674471"}}